Clinical Trials in Georgia

Showing 8821-8840 of 19,050 trials

Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)

NCT05205915

This is an open label pilot feasibility telemedicine study. This pilot will involve a total of 37 at-home stimulation sessions (30-minutes each) of multichannel excitatory tDCS targeting the left dorsolateral prefrontal cortex (DLPFC) administered over 8 weeks, with a follow-up period of 4 weeks following the final stimulation session.

Major Depressive Disorder

Neuroelectrics Corporation34 participantsStarted Feb 2022

Coral Springs, Florida, United States • Miami, Florida, United States • Snellville, Georgia, United States +1 more locations

COMPLETEDPhase 365 miles

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

NCT03465722

This is an open-label, randomized, Phase 3 study in patients with locally advanced unresectable or metastatic GIST (advanced GIST) of avapritinib (also known as BLU-285) versus regorafenib in patients previously treated with imatinib and 1 or 2 other TKIs.

GIST

Blueprint Medicines Corporation476 participantsStarted Mar 2018

Phoenix, Arizona, United States • Santa Monica, California, United States • Aurora, Colorado, United States +111 more locations

Home-based Transcranial Direct Current Stimulation (tDCS) for Major Depressive Disorders (MDD)

(VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST

Find Trials by Condition in Georgia

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Dialectical Behavior Therapy for Pregnant Women

Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa

A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry

Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

Dysport® Adult Upper Limb Spasticity

A Study in Subjects With Recurrent Malignant Glioma

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Natural History of Optic Neuritis

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors

Long-Term Retention of Gadolinium in Bone